Cipher Pharmaceuticals Inc (CPH_TSE) earnings
Quarterly and annual CPH_TSE reports and results, each read against the price at its own news timestamp. Back to the CPH_TSE overview →
19 measured CPH_TSE earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cipher Pharmaceuticals Reports Second Quarter 2026 Results | Press release | — | — | |
| Cipher Pharmaceuticals Schedules Q2 2026 Earnings Release and Conference Call | Press release | — | — | |
| Cipher Pharmaceuticals Reports First Quarter Results | Press release | — | — | |
| Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call | Press release | — | — | |
| Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings | Press release | — | — | |
| Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call | Press release | — | — | |
| Cipher Pharmaceuticals Reports Third Quarter 2025 Results | Press release | — | — | |
| Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call | Press release | — | — | |
| Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue | Press release | — | — | |
| Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call | Press release | — | — | |
| Cipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayment | Press release | — | — | |
| Cipher Pharmaceuticals Schedules Q1 2025 Earnings Release and Conference Call | Press release | — | — | |
| Cipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call | Press release | — | — | |
| Cipher Pharmaceuticals Reports Third Quarter 2024 Results | Press release | — | — | |
| Cipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference Call | Press release | — | — | |
| Cipher Pharmaceuticals Reports Second Quarter 2024 Results | Press release | -0.21% | +3.22% | |
| Cipher Pharmaceuticals Schedules Q2 2024 Earnings Release and Conference Call | Press release | +0.00% | -1.38% | |
| Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023 | Press release | -0.60% | +3.00% | |
| Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call | Press release | +0.00% | -2.24% |
Keep exploring
More CPH_TSE: analyst actions → · SEC filings → · CPH_TSE overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Eiger BioPharmaceuticals, Inc. (EIGR) | 45 | -1.57% | 32% |
| OTSUKA HOLDINGS CO ADR (OTSKY) | 45 | -0.06% | 39% |
| Navidea Biopharmaceuticals, Inc. (NAVB) | 43 | +5.93% | 82% |
| POLYDEX PHARMS LTD (POLXF) | 43 | 0.00% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.